Somnius Kft.
- Address
- lock Available on a paid plan
Somnius Kft. - Sleep Disorders Research Center
Somnius Kft. is a specialized clinical research center dedicated to advancing the understanding and treatment of sleep-wake disorders. The center focuses on conducting pivotal clinical trials for novel therapeutic interventions targeting debilitating sleep conditions, with particular expertise in neurological sleep disorders and their impact on patients' daily functioning.
- Narcolepsy Type 1 (Narcolepsy with Cataplexy) treatment development
- Excessive Daytime Sleepiness (EDS) assessment and management
- Innovative pharmacological interventions for sleep-wake regulation
The research center employs validated clinical outcome measures such as the Epworth Sleepiness Scale (ESS) to evaluate treatment efficacy in narcolepsy with cataplexy, ensuring rigorous scientific assessment of therapeutic candidates. Through participation in multi-phase clinical trials, Somnius Kft. contributes to developing breakthrough medications that address the core symptoms of excessive daytime sleepiness and improve quality of life for patients living with challenging sleep disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Amgen Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Somnius Kft.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Maridebart Cafraglutide in Adults with Moderate to Severe Obstructive Sleep Apnea and Overweight or Obesity Receiving Positive Airway Pressure Therapy | Amgen Inc. | Phase III | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Maridebart Cafraglutide | 1 | Unknown | 2026-02-17 | 2026-02-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.